CAD & Atherosclerosis
Conference Coverage
New CETP inhibitor impresses in LDL lowering
A new lipid-lowering agent, obicetrapib, in a class that had been written off by many, is being developed by a group of academic experts, with new...
Conference Coverage
Empagliflozin a winner in challenging arena of stabilized acute HF
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of...
Conference Coverage
Long-term glucocorticoids in RA linked to increased cardiovascular risk
Given the range of other therapies now available, avoiding long-term use of glucocorticoids for rheumatoid arthritis can reduce excess risk of...
Conference Coverage
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a...
Conference Coverage
ASCEND: Aspirin shows hint of dementia protection in T2D
Conference Coverage
Vegetable fats tied to lower stroke risk, animal fats to higher risk
Higher intake of vegetable fats, such as olive oil and nuts, was associated with a lower risk for stroke, and animal fats, especially processed...
Conference Coverage
CABG safe 3 days after stopping ticagrelor: RAPID CABG
A new randomized trial showed similar rates of severe bleeding in patients going to surgery at 3 days and 6 days after stopping the antiplatelet...
Conference Coverage
VEST: External sheath for CABG vein grafts shows promise
From the Journals
Treating young adults with high LDL may be cost-effective
About one-fourth of young adults have LDL levels ≥130 mg/dL, and treating them with statins would be cost-effective for primary CVD prevention.
Conference Coverage
AHA 2021 puts scientific dialogue, health equity center stage
The Scientific Sessions are fully online but with a heavy emphasis on live events and opportunities to interact globally over the latest...
Conference Coverage
At 5 years, iFR found as effective and safe as FFR for guiding PCI intervention
Five-year data reinforce prior finding: iFR and FFR are comparably effective and safe for guiding revascularization.